Adicet Bio, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
131 DARTMOUTH STREET, BOSTON, MA, 02116
Mailing Address
131 DARTMOUTH STREET, BOSTON, MA, 02116
Phone
617-482-2333
Fiscal Year End
1226
EIN
813305277
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13D/A Beneficial ownership amendment | April 10, 2026 | View on SEC |
| 4 Insider stock transaction report | April 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 12, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Pioneering 'off-the-shelf' gamma delta T cell therapy with lead candidate prula-cel (ADI-001) in Phase 1/2 trials for B-cell non-Hodgkin lymphomas.
- Strategic pivot in late 2023, including a 25% workforce reduction and pipeline prioritization, to conserve capital and extend cash runway.
Material Events
8-K
Strategy Change
December 29, 2025
High Impact
- Adicet Bio, Inc. announced a 1-for-16 reverse stock split to consolidate shares.
- The primary goal of the split is to increase the stock price per share to meet Nasdaq listing requirements and potentially attract institutional investors.
8-K
Financial Distress
December 19, 2025
High Impact
- Adicet Bio, Inc. shareholders approved a reverse stock split at a Special Meeting on December 19, 2025.
- The reverse stock split ratio will be determined by the board of directors, ranging from 1-for-5 to 1-for-30.
Insider Trading
STRONG SELL
1 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.